Capricor Therapeutics's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Capricor Therapeutics is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.11. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 12.09M	$ 6.19M	$ 3.92M	$ 2.99M	$ 959.90K
Gross Profit	$ 12.09M	$ 6.19M	$ 3.92M	-	-
EBIT	$ -721.92K	$ -6.36M	$ -7.35M	$ -7.81M	$ -7.70M
EBITDA	$ -414.31K	$ -6.09M	$ -7.09M	$ -7.58M	$ -7.51M
Net Income Common Stockholders	$ -762.10K	$ -6.36M	$ -7.37M	$ -7.81M	$ -7.70M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 39.49M	$ 28.52M	$ 37.79M	$ 45.17M	$ 41.42M
Total Assets	$ 58.73M	$ 37.15M	$ 45.98M	$ 53.86M	$ 50.09M
Total Debt	$ 5.61M	$ 5.79M	$ 5.60M	$ 5.77M	$ 5.94M
Net Debt	$ -33.88M	$ -22.73M	$ -32.19M	$ -39.40M	$ -35.48M
Total Liabilities	$ 36.13M	$ 38.94M	$ 43.28M	$ 47.66M	$ 38.31M
Stockholders Equity	$ 22.60M	$ -1.79M	$ 2.73M	$ 6.21M	$ 11.79M
Cash Flow	-
Free Cash Flow	$ -12.15M	$ -9.06M	$ -9.55M	$ 3.86M	$ -7.60M
Operating Cash Flow	$ -11.59M	$ -8.79M	$ -9.42M	$ 4.21M	$ -6.90M
Investing Cash Flow	$ -5.86M	$ 7.72M	$ 6.46M	$ -3.21M	$ 5.14M
Financing Cash Flow	$ 23.17M	$ 221.08K	$ 2.19M	$ 3.90K	$ 2.95M

Currency in USD

Capricor Therapeutics Earnings and Revenue History

Income Statement >

Capricor Therapeutics Debt to Assets

Balance Sheet >

Capricor Therapeutics Cash Flow

Cash Flow >

Capricor Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing